calendar
3,582 catalysts · 3,290 8k filing · 571 earnings · 115 phase 2 completion · 53 phase 1 completion · 28 phase 1 2 completion · 26 phase 1 initiation
3,582 catalysts · 3,290 8k filing · 571 earnings · 115 phase 2 completion · 53 phase 1 completion · 28 phase 1 2 completion · 26 phase 1 initiation
Items: 2.02, 9.01
Items: 2.02, 5.02, 9.01
Items: 1.01, 2.03, 9.01
Items: 8.01
Items: 1.01, 2.03, 3.02, 9.01
Items: 1.01, 9.01
Items: 1.01, 3.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 9.01
Items: 2.02, 9.01
Items: 5.07
Items: 1.01, 5.08, 9.01
Items: 8.01, 9.01
Items: 5.02
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Items: 8.01, 9.01
Items: 1.01, 2.03, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.02, 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.02, 5.07, 9.01
Items: 2.02, 9.01
Items: 4.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 5.02, 9.01
Items: 5.03, 9.01
Items: 5.07, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 3.01, 9.01
Items: 7.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 5.02, 9.01
Items: 8.01
Items: 5.02
Items: 1.01, 7.01, 9.01
Items: 5.02
Items: 7.01, 9.01